Skip to content

Unani treatment of diffuse hair loss

Efficacy of Itrifal kishneezi and Sufoof Gesu Daraaz in Diffuse Hair Loss (Inteshar Al-Shaâ??r) â?? An Open Labelled, Single Arm Clinical Trial - DHL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/031612
Enrollment
30
Registered
2021-03-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L658- Other specified nonscarring hair loss

Interventions

Intervention1: Itrifal Kishneezi And Sufoof Gesu Daraaz: Patients will receive a Test Drug (Itrifal kishneezi and Sufoof Gesu Daraaz) for oral and local application respectively. Intervention2: Itrifa

Sponsors

National Institute of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of DHL 2. Female patients with age 18-50 years. 3. Hair loss more than 200 per day 4. Cases of DHL precipitated by following conditions such as typhoid, other febrile illness, major surgery, psychological stress, nutritional deficiencies and crash dieting.

Exclusion criteria

Exclusion criteria: 1. Patients 50 yrs. 2. Patients having other disease like scalp psoriasis, tinea capitis, seborrhic dermatitis, congenital alopecia, Androgenetic alopecia, alopecia areata, scarring alopecia, lichen planopilaris and trichotillomania. 3. Pregnant and lactating mothers 4. A patient suffering from DM, malignancy, or any organ dysfunction. 5. Received any other medical therapy for DHL within a period of 15 days. 6. Done any surgical correction of scalp hair loss.

Design outcomes

Primary

MeasureTime frame
Hair shedding Visual ScaleTimepoint: every 15 days

Secondary

MeasureTime frame
Dermatological Life Quality Index (DLQI)Timepoint: every 15 days

Countries

India

Contacts

Public ContactFarzana Ahkter

National Institute Of Unani Medicine

mansoorsiddiquidr@gmail.com9448124054

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026